| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| E K El-Sayed, Aae Ahmed, Em El Morsy, S Nofa. Neuroprotective effect of agmatine (decarboxylated l-arginine) against oxidative stress and neuroinflammation in rotenone model of Parkinson's disease. Human & experimental toxicology. vol 38. issue 2. 2019-03-07. PMID:30001633. |
parkinson's disease (pd) is the second most common age-related neurodegenerative disease after alzheimer's disease, characterized by loss of dopaminergic neurons in substantia nigra pars compacta, accompanied by motor and nonmotor symptoms. |
2019-03-07 |
2023-08-13 |
rat |
| Dong-Xia Wang, Jun-Xia Xie, Ning Son. [GBA mutations and Parkinson's disease]. Sheng li xue bao : [Acta physiologica Sinica]. vol 70. issue 3. 2019-01-04. PMID:29926071. |
parkinson's disease (pd) is a common neurodegenerative disease characterized by the degeneration of dopaminergic neurons in the substantia nigra and the intraneuronal lewy bodies in this area. |
2019-01-04 |
2023-08-13 |
Not clear |
| Tsai-Hua Chung, Szu-Chun Hsu, Shu-Hui Wu, Jong-Kai Hsiao, Chih-Peng Lin, Ming Yao, Dong-Ming Huan. Dextran-coated iron oxide nanoparticle-improved therapeutic effects of human mesenchymal stem cells in a mouse model of Parkinson's disease. Nanoscale. vol 10. issue 6. 2019-01-02. PMID:29372743. |
parkinson's disease (pd) is a prevalent neurodegenerative disease characterized by the loss of dopaminergic (da) neurons. |
2019-01-02 |
2023-08-13 |
mouse |
| Rosalia Crupi, Daniela Impellizzeri, Marika Cordaro, Rosalba Siracusa, Giovanna Casili, Maurizio Evangelista, Salvatore Cuzzocre. N-palmitoylethanolamide Prevents Parkinsonian Phenotypes in Aged Mice. Molecular neurobiology. vol 55. issue 11. 2018-12-17. PMID:29552727. |
parkinson's disease (pd) is a neurodegenerative disease characterized by degeneration of dopaminergic neurons. |
2018-12-17 |
2023-08-13 |
mouse |
| Jeongah Kim, Sangwon Jang, Mijung Choi, Sooyoung Chung, Youngshik Choe, Han Kyoung Choe, Gi Hoon Son, Kunsoo Rhee, Kyungjin Ki. Abrogation of the Circadian Nuclear Receptor REV-ERBα Exacerbates 6-Hydroxydopamine-Induced Dopaminergic Neurodegeneration. Molecules and cells. vol 41. issue 8. 2018-12-17. PMID:30078232. |
parkinson's disease (pd) is a neurodegenerative disease characterized by progressive degeneration of dopaminergic (daergic) neurons, particularly in the substantia nigra (sn). |
2018-12-17 |
2023-08-13 |
mouse |
| Patricia Villacé, Rosa M Mella, Meritxell Roura-Ferrer, María Valcárcel, Clarisa Salado, Amaia Castilla, Danel Kortaza. Fluorescent Parkin Cell-Based Assay Development for the Screening of Drugs against Parkinson Disease. SLAS discovery : advancing life sciences R & D. vol 22. issue 1. 2018-12-11. PMID:27703082. |
parkinson disease (pd) is a prevalent neurodegenerative disease characterized by selective degeneration of dopaminergic neurons in the substantia nigra, causing tremor and motor impairment. |
2018-12-11 |
2023-08-13 |
Not clear |
| Guifang Wang, Weibin Ma, Jingwei D. β-Caryophyllene (BCP) ameliorates MPP+ induced cytotoxicity. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. vol 103. 2018-11-13. PMID:29710667. |
parkinson's disease (pd) is one of the most common neurodegenerative diseases resulting from the continuous death of dopaminergic neurons in substantia nigra. |
2018-11-13 |
2023-08-13 |
Not clear |
| Shiqing Zhang, Ruili Feng, Yanhui Li, Linhua Gan, Fangfang Zhou, Shiquan Meng, Qian Li, Tieqiao We. Degradation of alpha-synuclein by dendritic cell factor 1 delays neurodegeneration and extends lifespan in Drosophila. Neurobiology of aging. vol 67. 2018-10-04. PMID:29649746. |
parkinson's disease (pd) is a common neurodegenerative disease associated with the progressive loss of dopaminergic neurons in the substantia nigra. |
2018-10-04 |
2023-08-13 |
mouse |
| Ming Hu, Fangming Li, Weidong Wan. Vitexin protects dopaminergic neurons in MPTP-induced Parkinson's disease through PI3K/Akt signaling pathway. Drug design, development and therapy. vol 12. 2018-09-17. PMID:29588573. |
parkinson's disease (pd) is a progressive neurodegenerative disease which is characterized by the degeneration of dopaminergic neurons in the substantia nigra pars compacta (snpc). |
2018-09-17 |
2023-08-13 |
Not clear |
| Erfath Thanjeem Begum Moghal, Katari Venkatesh, Dwaipayan Se. The delta opioid peptide D-Alanine 2, Leucine 5 Enkephaline (DADLE)-induces neuroprotection through cross-talk between the UPR and pro-survival MAPK-NGF-Bcl2 signaling pathways via modulation of several micro-RNAs in SH-SY5Y cells subjected to ER stress. Cell biology international. vol 42. issue 5. 2018-09-10. PMID:29271539. |
parkinson's disease (pd) is the second most progressive neurodegenerative disease characterized by the loss of dopaminergic neurons and accumulation of misfolded proteins in endoplasmic reticulum (er) leading to activation of the unfolded protein response (upr). |
2018-09-10 |
2023-08-13 |
Not clear |
| Hermínio Maurício da Rocha Sobrinho, Delson José da Silva, Larissa Fonseca Gomides, Miriam Leandro Dorta, Milton Adriano Pelli de Oliveira, Fátima Ribeiro-Dia. TLR4 and TLR2 activation is differentially associated with age during Parkinson's disease. Immunological investigations. vol 47. issue 1. 2018-08-16. PMID:29077524. |
parkinson's disease (pd) is an age-related neurodegenerative disease characterized by loss of dopaminergic neurons associated with neuroinflammation. |
2018-08-16 |
2023-08-13 |
Not clear |
| Cai-xia Zang, Xiu-qi Bao, Hua Sun, Dan Zhan. [The role of neuroinflammation-related regulatory targets in the treatment for Parkinson’s disease]. Yao xue xue bao = Acta pharmaceutica Sinica. vol 51. issue 5. 2018-08-10. PMID:29874003. |
parkinson’s disease(pd) is a neurodegenerative disease characterized by the degeneration of dopaminergic neurons. |
2018-08-10 |
2023-08-13 |
Not clear |
| Ori J Lieberman, Se Joon Choi, Ellen Kanter, Anastasia Saverchenko, Micah D Frier, Giulia M Fiore, Min Wu, Jyothisri Kondapalli, Enrico Zampese, D James Surmeier, David Sulzer, Eugene V Mosharo. α-Synuclein-Dependent Calcium Entry Underlies Differential Sensitivity of Cultured SN and VTA Dopaminergic Neurons to a Parkinsonian Neurotoxin. eNeuro. vol 4. issue 6. 2018-07-25. PMID:29177188. |
parkinson's disease (pd) is a debilitating neurodegenerative disease characterized by a loss of dopaminergic neurons in the substantia nigra (sn). |
2018-07-25 |
2023-08-13 |
mouse |
| Karim Belarbi, Elodie Cuvelier, Alain Destée, Bernard Gressier, Marie-Christine Chartier-Harli. NADPH oxidases in Parkinson's disease: a systematic review. Molecular neurodegeneration. vol 12. issue 1. 2018-07-24. PMID:29132391. |
parkinson's disease (pd) is a progressive movement neurodegenerative disease associated with a loss of dopaminergic neurons in the substantia nigra of the brain. |
2018-07-24 |
2023-08-13 |
Not clear |
| Xiao-Liang Liu, Ying-Di Wang, Xiu-Ming Yu, Da-Wei Li, Guang-Ren L. Mitochondria-mediated damage to dopaminergic neurons in Parkinson's disease (Review). International journal of molecular medicine. vol 41. issue 2. 2018-07-23. PMID:29207041. |
mitochondrial abnormalities have been implicated in a wide range of disorders, including neurodegenerative disease such as parkinson's disease (pd), and considered as a primary cause and central event responsible for the progressive loss of dopaminergic neurons in pd. |
2018-07-23 |
2023-08-13 |
Not clear |
| Natalia Areiza Mazo, Valentina Echeverria, Ricardo Cabezas, Marco Avila-Rodriguez, Vadim V Tarasov, Nagendra S Yarla, Gjumrakch Aliev, George E Barret. Medicinal Plants as Protective Strategies Against Parkinson's Disease. Current pharmaceutical design. vol 23. issue 28. 2018-07-05. PMID:28302024. |
parkinson's disease is a neurodegenerative disease caused by the loss of dopaminergic neurons in the substantia nigra pars compacta region. |
2018-07-05 |
2023-08-13 |
Not clear |
| Jingjing He, Zheng Xiang, Xiaoqing Zhu, Zongyong Ai, Jingsong Shen, Tianzhuang Huang, Liegang Liu, Weizhi Ji, Tianqing L. Neuroprotective Effects of 7, 8-dihydroxyflavone on Midbrain Dopaminergic Neurons in MPP Scientific reports. vol 6. 2018-06-12. PMID:27731318. |
neuroprotective effects of 7, 8-dihydroxyflavone on midbrain dopaminergic neurons in mpp parkinson's disease (pd) is one common neurodegenerative disease caused by a significant loss of midbrain dopaminergic neurons. |
2018-06-12 |
2023-08-13 |
mouse |
| Jia Liu, Xue Wang, Yongquan Lu, Chunli Duan, Ge Gao, Lingling Lu, Hui Yan. Pink1 interacts with α-synuclein and abrogates α-synuclein-induced neurotoxicity by activating autophagy. Cell death & disease. vol 8. issue 9. 2018-06-05. PMID:28933786. |
parkinson's disease (pd) is one of the most common neurodegenerative diseases, characterized by degeneration of dopaminergic neurons in the substantia nigra. |
2018-06-05 |
2023-08-13 |
Not clear |
| Sujung Yeo, Backil Sung, Yeon-Mi Hong, Maurits van den Noort, Peggy Bosch, Sook-Hyun Lee, Jongbeom Song, Sang-Kyun Park, Sabina Li. Decreased expression of serum- and glucocorticoid-inducible kinase 1 (SGK1) promotes alpha-synuclein increase related with down-regulation of dopaminergic cell in the Substantia Nigra of chronic MPTP-induced Parkinsonism mice and in SH-SY5Y cells. Gene. vol 661. 2018-05-30. PMID:29604467. |
parkinson's disease (pd) is a chronically progressive neurodegenerative disease, with its main pathological hallmarks being a dramatic loss of dopaminergic neurons predominantly in the substantia nigra (sn), and the formations of intracytoplasmic lewy bodies and dystrophic neurites. |
2018-05-30 |
2023-08-13 |
mouse |
| Wen Lv, Qiongfeng Guan, Xingyue Hu, Jiaqi Chen, Hong Jiang, Lisan Zhang, Weinv Fa. Vestibulo-ocular reflex abnormality in Parkinson's disease detected by video head impulse test. Neuroscience letters. vol 657. 2018-05-28. PMID:28807728. |
parkinson's disease (pd) is a common neurodegenerative disease characterized by dopaminergic neuronal loss. |
2018-05-28 |
2023-08-13 |
Not clear |